Condensed unaudited interim consolidated financial statements of Helix BioPharma Corp. for the three and nine month periods ended April 30, 2016 and 2015
FY2016
FY2016
Condensed unaudited interim consolidated financial statements of Helix BioPharma Corp. for the three and nine month periods ended April 30, 2016 and 2015